Ensysce Biosciences (ENSC) Misses Q2 EPS by 79c
Get Alerts ENSC Hot Sheet
Join SI Premium – FREE
Ensysce Biosciences (NASDAQ: ENSC) reported Q2 EPS of ($0.79). Revenue for the quarter came in at $1.37 million.
For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- Business First Bancshares, Inc. (BFST) Tops Q2 EPS by 1c
- (ECBK) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share